The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Makhneva N.V.

Moskovskiĭ nauchno-prakticheskiĭ tsentr dermatovenerologii i kosmetologii Departamenta zdravookhraneniia

Nefedova E.D.

Filial "Veshniakovskiĭ" Moskovskogo nauchno-prakticheskogo tsentra dermatovenerologii i kosmetologii Departamenta zdravookhraneniia Moskvy

Pomerantsev O.N.

Moskovskiĭ nauchno-prakticheskiĭ tsentr dermatovenerologii i kosmetologii Departamenta zdravookhraneniia

Beletskaia L.V.

FGU "Federal'nyĭ nauchnyĭ tsentr transplantologii i iskusstvennykh organov im. V.I. Shumakova" Minzdrava Rossii, Moskva

The course and diagnosis of acquired epidermolysis bullosa (a clinical and immunopathological observation)

Authors:

Makhneva N.V., Nefedova E.D., Pomerantsev O.N., Beletskaia L.V.

More about the authors

Read: 2776 times


To cite this article:

Makhneva NV, Nefedova ED, Pomerantsev ON, Beletskaia LV. The course and diagnosis of acquired epidermolysis bullosa (a clinical and immunopathological observation). Russian Journal of Clinical Dermatology and Venereology. 2013;11(2):92‑97. (In Russ.)

Recommended articles:
Dermatofibroma and keloid scar: simi­larities and differences. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):558-564
Issues of morphological diagnosis and pathogenesis of tube­rculosis. Russian Journal of Archive of Pathology. 2024;(5):81-93
Tube­rculous otitis media in an adolescent. Clinical case. Russian Bulletin of Otorhinolaryngology. 2024;(5):63-66
Giant peri­cranial sinus with exte­nsive occi­pital calvarium defect. Burdenko's Journal of Neurosurgery. 2024;(6):77-87
Difficulties in life­time diagnosis of Creutzfeldt—Jakob disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):19-27
Clinical case of auri­cular gouty tophi. Russian Bulletin of Otorhinolaryngology. 2024;(6):80-84

References:

  1. Bernard P., Vaillant L., Labeille B., Bedane C., Arbeille B., Denoeux J.P., Lorette G., Bonnetblanc J.M., Prost C. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Arch Dermatol 1995; 131: 48-52.
  2. Zillikens D., Wever S., Roth A., Hashimoto T., Brocker E.B. Incidence of autoimmune subepidermal blistering dermatosis in region of central Germany. Arch Dermatol 1995; 131: 957-958.
  3. Lee C.W. Prevalences of subacute cutaneous lupus erythematosus and epidermolysis bullosa acquisita among Korean/oriental papulation. Dermatology 1998; 197: 187.
  4. Makhneva N.V., Beletskaya L.V. Immunopatologicheskie aspekty autoimmunnykh bulleznykh dermatozov (klinika, diagnostika, etiologiya, patogenez i molekulyarno-biologicheskie osobennosti). Palmarium Academic Publishing 2012; 411.
  5. Chen M., Chan L.S., Cai X., O'Toole E.A., Sample J.C., Woodley D.T. Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. J Invest Dermatol 1997; 108: 68-72.
  6. Woodley D.T., Briggaman R.A., O'Keefe E.J., Inman A.O., Queen L.L., Gammon W.R. Identification of the skin basement-autoantigen in epidermolysis bullosa acquisita. N Engl J Med 1984; 310: 1007-1015.
  7. Woodley D.T., Gammon W.R., Briggaman R.A. Epidermolysis bullosa acquisita. In: Dermatology in general medicine. Eds. T.B. Fitzpatrick, A.Z. Eisen, K. Wolff, I.M. Freedberg, K.F. Austen. 4th ed. V. I-II. New York: McGraw-Hill 1998; 702-709.
  8. Woodley D., Chang C., Saadat P., Ram R., Liu Z., Chen M. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J Invest Dermatol 2005; 124: 5: 958-964.
  9. Gammon W.R. Immunohistology of cutaneous diseases. Immunohistology in Diagnostic Pathology. Ed. J.C. Jemmette. Florida: Boca Raton 2000; 85-117.
  10. Yaoita H., Briggaman A., Lawley T.J., Provost T.T., Katz S.I. Epidermolysis bullous acquisita: Ultrastructural and immunological studies. J Invest Dermatol 1981; 76: 288-292.
  11. Potekaev N.S., Ivanov O.L., Shuginina E.A., Pal'tsev M.A. Priobretennyi bulleznyi epidermoliz v sochetanii s trombotsitopeniei. Vestn dermatol 1985; 1: 56-61.
  12. Chen M., Hallel-Halevy D., Nadelman C., Woodley D.T. Epidermolysis bullosa acquisita. In: Autoimmune diseases of the skin. Ed. M. Hertl. Wien-NewYork: Springer 2005; 109-132.
  13. Roenigk H.H., Ryan J.C., Bergfeld W.F. Epidermolysis bullous acquisita: Report of three cases and review of all published cases. Arch Dermatol 1971; 103: 1-10.
  14. Kryazheva S.S., Makhneva N.V. Uspeshnoe lechenie priobretennogo bulleznogo epidermoliza prednizolonom i sandimmunom. Ros zhurn kozhn i ven bol 1999; 1: 38-41.
  15. Gupta R., Woodley D.T., Chen M. Epidermolysis bullosa acquisita. Clin Dermatol 2012; 30: 1: 60-69.
  16. Cunningham B.B., Kirchmann T.T., Woodley D. Colchicine for epidermolysis bullosa acquisita. J Am Acad Dermatol 1996; 34: 781-784.
  17. Habif T.P. Clinical Dermatology. 3-d ed. Baltimore; New York 1995: 518-519.
  18. Callot-Mellot C., Bodemer C., Caux F., Bourgault-Villada I., Fraitag S., Goudie G., Heller M., de Prost Y., Prost C. Epidermolysis bullosa acquisita in childhood. Arch Dermatol 1997; 133: 1122-1126.
  19. Jonkman M.F., Schuur J., Dijk F., Heeres K., de Jong M.C., van der Meer J.B., Yancey K.B., Pas H.H. Inflammatory variant of epidermolysis bullosa asquisita with IgG autoantibodies against type VII collagen and laminin alpha3. Arch Dermatol 2000; 136: 2: 227-231.
  20. Elliot G.T. Two cases of epidermolysis bullosa. J Cutan Genitourin Dis 1895; 13: 10.
  21. Briggaman R.A., Wheeler C.E.Jr. The epidermal-dermal junction. J Invest Dermatol 1975; 65: 71-84.
  22. Briggaman R.A., Gammon W.R. Epidermolysis bullosa acquisita and other acquired blistering diseases manifesting autoimmunity to type VII collagen. In: Bullous disease. Eds. T.T. Provost, W.L. Weston. St. Louis: Mosby Year Book Inc 1993; 115-156.
  23. Czarny-Ratajczak M., Latos-Bielenska A. Collagens, the basic proteins of the human body. J Appl Genet 2000; 41: 317-330.
  24. Franzke C.W., Tasanen K., Schumann H., Bruckner-Tuderman L. Collagenous transmembrane proteins: collagen XVII as prototype. Matrix Biol 2003; 22: 299-309.
  25. Uitto J., Christiano A.M. Molecular basis for the dystrophic forms of epidermolysis bullosa: mutations in the type VII collagen gene. Arch Dermatol 1994; 287: 16-22.
  26. Christiano A.M., Uitto I. Molecular complexity of the cutaneous basement membrane zone. Exp Dermatol 1996; 5: 1-11.
  27. Franzke C.W., Tasanen K., Borradori L., Huotari V., Bruckner-Tuderman L. Shedding of collagen XVII/BP180: structural motifs influence cleavage from cell surface. J Biol Chem 2004; 279: 24521-24529.
  28. Burgeson R.E. Type VII collagen, anchoring fibrils and epidermolysis bullosa. J Invest Dermatol 1993; 101: 252-255.
  29. Eady R.A., McGrath J.A., McMillan J.R. Ultrastructural clues to genetic disorders of skin: the dermal-epidermal junction. J Invest Dermatol 1994; 103: Suppl 5: 13S-18S.
  30. Fine J.D., Tyring S., Gammon W.R. The presence of intralamina lucida blister formation in epidermolysis bullosa acquisita: possible role of leukocytes. J Invest Dermatol 1989; 92: 27-32.
  31. Remington J., Chen M., Burnett J., Woodley D.T. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita. Curr Dir Autoimmun 2008; 10: 195-205.
  32. Borradori L., Caldwell J.B., Briggaman R.A., Burr C.E., Gammon W.R., James W.D., Yancey K.B. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice. Arch Dermatol 1995; 131: 590-595.
  33. Sitaru C., Mihai S., Otto C., Chiriac M.T., Hauber I., Dotterweich B., Saito H., Rose C., Ishiko A., Zillikens D. Induction of dermal-epidermal separation in mice by passive transfer of antibodies to type VII collagen. J Clin Invest 2005; 115: 870-878.
  34. Woodley D.T., Ram R., Doostan A., Bandyopadhyaya P., Huang Yi., Remington J., Hou Y., Keen D.R., Liu Z., Chen M. Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients. J Invest Dermatol 2006; 126: 1323-1330.
  35. Lally A., Chamberlain A., Allen J., Dean D., Wojnarowska P. Dermal-binding linear IgA diseases: an uncommon subset of a rare immunobullous disease. Clin Exp Dermatol 2007; 32: 493-498.
  36. Lee C.W. Serum IgA autoantibodies in patients with epidermolysis bullosa acqusita: a high frequency of detection. Dermatology 2000; 200: 83-84.
  37. Vodegel R.M., de Jong M.C., Pas H.H., Jonkman M.F. IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature. J Am Acad Dermatol 2002; 47: 6: 919-925.
  38. Makhneva N.V., Beletskaya L.V. Immunoflyuorestsentsiya v klinike autoimmunnykh bulleznykh dermatozov. Posobie dlya vrachei. M: Akademiya estestvoznaniya 2010.
  39. Chan L.S., Stone O.J. Epidermolysis Bullosa Acquisita Follow-up. Professor of Dermatology, Head, Department of Dermatology, University of Illinois College of Medicine. Medscape Ref 2011.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.